A Phase 2 trial is testing a weekly intranasal spray that primes early immune defenses to reduce respiratory virus illness.

ETHealthworld.com brings latest nasal spray news, views and updates from all top sources for the Indian Health industry.

A few months after sending an untitled letter to ARS Pharmaceuticals, taking issue with certain aspects of a TV commercial about its epinephrine nasal spray, the FDA is reiterating its concerns about ...

Last year, at least one million people in the U.S. were hospitalized for respiratory virus illnesses like the flu or COVID-19 ...

This chart summarizes the case name, presiding judge, drug, and patents-at-issue in all federal district court cases that are ...

Dylan Rocha, 21, died after unknowingly taking a nitazene - a drug up to 500 times stronger than heroin. | ITV News Meridian ...

Aquestive Therapeutics said on Monday the U.S. FDA has declined to approve its oral drug for severe allergic reactions due to ...

Researchers developed an intranasal H5N1 vaccine that protected mice and hamsters from bird flu infection. The vaccine was ...

In this edition of The People’s Pharmacy, Joe and Teresa Graedon also hear from a physician who supports testosterone ...

Opvee reverses opioid overdose more quickly than Narcan. It also can cause withdrawal symptoms. Harm reduction advocates fought it, and won.

The residential Southwest Area held a NARCAN administration training for students Tuesday afternoon at Willard Residential ...

In a second warning letter, the agency calls out what it says are misleading claims and images in the nasal anaphylaxis ...